Order Hepcinat LP Tablets By Natco Pharma
Hepcinat contains polymerase inhibitor sofosbuvir+ledipasvir which approved for the treatment of patients infected with hepatitis C genotype 1 and 4. Sofosbuvir & Ledipasvir is the first FDA-approved treatment protocol for HCV infection, which does not require interferon or ribavirin. In the clinical studies have proven extremely high success rate of sofosbuvir in couple with ledipasvir.
TRADE NAME HEPCINAT LP IS GENERIC VERSION OF SOFOSBUVIR AND LEDIPASVIR.